TY - JOUR
T1 - Cytomegalovirus infection
T2 - A seroepidem1ologic study of a recruit population
AU - Wenzel, Richard P.
AU - McCormick, David P.
AU - Da Vies, John A.
AU - Berling, Carl
AU - Beam, Walter E.
PY - 1973/6
Y1 - 1973/6
N2 - Wenzel, R. P., D. P. McCormick, J. A. Davies, C. Berling and W. E. Beam, Jr. (Naval Medical Field Res. Lab., Camp Lejeune, N.C. 28542). Cytomegalovirus infection: A seroepidemiologic study of a recruit population. Am J Epidemiol 97: 410-414, 1973.-A seroepidemiologic study of cytomegalovirus (CMV) infections was performed on a military base. Of 588 incoming recruits, 410 (69.7%) had no detectable (<2) CMV complement-fixing antibody. Six recruits (1%) had CMV antibody rises during the 14-week training period. One man with a CMV antibody rise was hospitalized with a 20-day history of marked generalized malaise and nocturnal diaphoresis. CMV antibody rises were not observed in 45 patients with etiologically undiagnosed acute respiratory disease. Similarly, no CMV antibody rises were observed in 35 patients with an infectious niononucleosis syndrome (three were monospot negative) or in 93 Australia antigen negative cases of viral hepatitis. All men who showed rises in CMV antibody had no detectable antibody when they arrived on base. These data suggest a limited communicability of CMV under the crowded conditions in which this recruit population lived. Low levels of CMV complement-fixing antibody may correlate with protection in the uncompromised host. Similar studies in the general population seem warranted. antibodies; complement fixation tests; cytomegaloviruses; recruits; respiratory tract infections; serology; virus diseases.
AB - Wenzel, R. P., D. P. McCormick, J. A. Davies, C. Berling and W. E. Beam, Jr. (Naval Medical Field Res. Lab., Camp Lejeune, N.C. 28542). Cytomegalovirus infection: A seroepidemiologic study of a recruit population. Am J Epidemiol 97: 410-414, 1973.-A seroepidemiologic study of cytomegalovirus (CMV) infections was performed on a military base. Of 588 incoming recruits, 410 (69.7%) had no detectable (<2) CMV complement-fixing antibody. Six recruits (1%) had CMV antibody rises during the 14-week training period. One man with a CMV antibody rise was hospitalized with a 20-day history of marked generalized malaise and nocturnal diaphoresis. CMV antibody rises were not observed in 45 patients with etiologically undiagnosed acute respiratory disease. Similarly, no CMV antibody rises were observed in 35 patients with an infectious niononucleosis syndrome (three were monospot negative) or in 93 Australia antigen negative cases of viral hepatitis. All men who showed rises in CMV antibody had no detectable antibody when they arrived on base. These data suggest a limited communicability of CMV under the crowded conditions in which this recruit population lived. Low levels of CMV complement-fixing antibody may correlate with protection in the uncompromised host. Similar studies in the general population seem warranted. antibodies; complement fixation tests; cytomegaloviruses; recruits; respiratory tract infections; serology; virus diseases.
UR - http://www.scopus.com/inward/record.url?scp=0015894081&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0015894081&partnerID=8YFLogxK
U2 - 10.1093/oxfordjournals.aje.a121522
DO - 10.1093/oxfordjournals.aje.a121522
M3 - Article
C2 - 4351617
AN - SCOPUS:0015894081
SN - 0002-9262
VL - 97
SP - 410
EP - 414
JO - American journal of epidemiology
JF - American journal of epidemiology
IS - 6
ER -